Chlordiazepoxide Hydrochloride And Clidinium Bromide
Product Images NDC 10135-622

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Chlordiazepoxide Hydrochloride And Clidinium Bromide (NDC 10135-622). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Marlex Pharmaceuticals Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

The Structural Formula Of Chlordiazepoxide Hydrochloride. (Chlordiazepoxide Hydrochloride And Clindinium Brom 01)

The Structural Formula Of Chlordiazepoxide Hydrochloride. (Chlordiazepoxide Hydrochloride And Clindinium Brom 01)
Chemical structure of Chlordiazepoxide Hydrochloride. The diagram shows the molecular arrangement including chlorine (Cl) substitution and the hydrochloride (HCl) component shown as a dot separate from the main structure.*
FDA Label Image

The Structural Formula Of Clidinium Bromide. (Chlordiazepoxide Hydrochloride And Clindinium Brom 02)

The Structural Formula Of Clidinium Bromide. (Chlordiazepoxide Hydrochloride And Clindinium Brom 02)
Chemical structure diagram showing the molecular configuration of clidinium bromide, one of the active ingredients in Chlordiazepoxide Hydrochloride and Clidinium Bromide by Marlex Pharmaceuticals Inc.*
FDA Label Image

Principal Display Panelndc 10135-0622-01chlordiazepoxidehcl And Clidiniumbromide Capsules5 mg / 2.5 mgrx Only100 Capsules (Chlordiazepoxide Hydrochloride And Clindinium Brom 03)

Principal Display Panelndc 10135-0622-01chlordiazepoxidehcl And Clidiniumbromide Capsules5 mg / 2.5 mgrx Only100 Capsules (Chlordiazepoxide Hydrochloride And Clindinium Brom 03)
Label for Chlordiazepoxide Hydrochloride and Clidinium Bromide Capsules, 5 mg / 2.5 mg, manufactured by Marlex Pharmaceuticals Inc. The label indicates 100 capsules in the package. It includes dosage details, storage instructions, tamper-evident information, and a barcode with NDC 10135-0622-01.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.